Chinook Tyee Industry Ltd Share Price Toronto S.E.
Equities
GBI.H
CA16961T2083
Pharmaceuticals
Sales 2021 | 453K 329K 26.32M | Sales 2022 | - | Capitalization | 3.43M 2.49M 200M |
---|---|---|---|---|---|
Net income 2021 | -3M -2.18M -174M | Net income 2022 | -1M -726K -58.12M | EV / Sales 2021 | 24.5 x |
Net Debt 2021 | 1.87M 1.36M 109M | Net Debt 2022 | 3.15M 2.28M 183M | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.14
x | P/E ratio 2022 |
-1.79
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 74.11% |
Managers | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 13/12/12 |
Director/Board Member | 72 | 04/12/18 | |
Investor Relations Contact | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tom Kusumoto
CEO | Chief Executive Officer | 54 | 13/12/12 |
Director/Board Member | 72 | 04/12/18 | |
Frank Otto
BRD | Director/Board Member | - | 10/05/22 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.01B | |
-18.38% | 4.4B | |
-9.17% | 3.17B | |
+3.98% | 3.07B | |
-3.41% | 2.51B | |
+48.74% | 1.88B | |
-4.82% | 1.73B | |
-1.24% | 1.65B | |
-8.96% | 1.58B |